{
  "pmcid": "7079046",
  "sha256": "492b023f8c8d9e50f8192c95d8b18a1ed695f9347c490d08526776a8082aad27",
  "timestamp_utc": "2025-11-10T00:04:12.455609+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 15.615361570247938,
    "reading_ease": 10.04758780991736,
    "word_count": 242
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of CEA-Specific Fluorescence Imaging in Cytoreductive Surgery for Colorectal Cancer"
      },
      "Trial_Design": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Participants": {
        "score": 2,
        "evidence": "Fourteen patients diagnosed with peritoneal metastases of colorectal origin were included."
      },
      "Intervention": {
        "score": 2,
        "evidence": "SGM-101 was administered intravenously 4â€“6 days before surgery."
      },
      "Objective": {
        "score": 1,
        "evidence": "This multicentre pilot study aimed to assess the role of carcinoembryonic antigen (CEA)-specific fluorescence imaging using SGM-101 during cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) in patients with peritoneal metastasized colorectal cancer."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the change in the peritoneal carcinomatosis index (PCI) due to fluorescence imaging, measured intraoperatively."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Randomisation and blinding details were not applicable as this was a pilot study."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Randomisation and blinding details were not applicable as this was a pilot study."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "Fourteen patients diagnosed with peritoneal metastases of colorectal origin were included."
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "A correct change in PCI due to fluorescence imaging was observed in 4 of the 14 patients."
      },
      "Harms": {
        "score": 1,
        "evidence": "SGM-101 was well tolerated, with no allergic or anaphylactic reactions reported."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "No trial registration or funding details were provided."
      },
      "Funding": {
        "score": 0,
        "evidence": "No trial registration or funding details were provided."
      }
    },
    "total_score": 12,
    "max_score": 25
  }
}